300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Zimbabwe
Tunisia
Sweden
Oceania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Angola
Barbados
Belgium
Cyprus
Jordan
Ethiopia
Azerbaijan
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Ecuador
Bahamas
Belize
Bolivia
Italy
Algeria
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Jinxin Capital

VC Fund

Jinxin Capital is a venture capital firm.

Total investments:
7
Last investment:
Lead investor:
14%

Last updated:

Industries Jinxin Capital invests in

MedicalHealth CareBiotechnologyMedical DeviceSolar

Stages Jinxin Capital invests in

SeedSeries ASeries BSeries D

Countries Jinxin Capital invests in

China

Investment Focus

Industry

  • Medical 6 (86%)
  • Health Care 4 (57%)
  • Biotechnology 2 (29%)
  • Medical Device 2 (29%)
  • Solar 1 (14%)
See all 10 industries →

Stage

  • Seed 2 (29%)
  • Series A 2 (29%)
  • Series B 2 (29%)
  • Series D 1 (14%)

Investments

CompanyDescriptionRoundLinks
GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules. $14.8M / Series D / Aug 03, 2026
Bangqi Biological is a biotechnology company that focuses on the research and development, production, registration, quality, supply chain and sales of instruments and reagents for autoimmunity & allergy diagnosis. Series B / Nov 27, 2024
Shengxing Medical Shengxing Medical
Shengxing Medical is a high-tech company that specializes in the research and development of medical imaging holographic preoperative planning systems, as well as holographic intelligent surgical positioning and navigation systems. $1.4M / Seed / Sep 12, 2024
Shineyo Medical is a provider of minimally invasive cardiovascular interventional treatment devices, focusing on electrophysiology and peripheral intervention. They aim to become a domestic provider of solutions for atrial fibrillation and varicose veins. $13.9M / Series A / Aug 12, 2024
Meishangjie Biotechnology
Meishangjie Biotechnology is a biotech firm that specializes in the genetic engineering synthetic biotechnology for medical skin care products. Series A / Jul 09, 2024
New Cloud Medical is the leading pain specialist medical association in China. It relies on the national key specialists, the Sino-Japanese Hospital Pain Specialist Medical Association, the national telemedicine platform, the top hospital brand and the expert resource library, making full use of the advantages of international pain disciplines.Construction of national, provincial, municipal, and county pain cloud platform grading clinics. Providing pain-specific specialty treatments to city-level and county-level public secondary hospitals, creating city-level and characteristic pain departments, improving the level of pain specialist treatment, and building a professional and comprehensive network of consultation consultations and a long-term scientific operation system. Series B / Sep 25, 2023
Jingcai Intelligent is an AI company that focuses on the continuous management of musculoskeletal pain and sports health. Jingcai Intelligent provides digital screening and functional evaluation, health An overall solution for management and scientific training. Seed / Jun 20, 2023

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Zimbabwe
Tunisia
Sweden
Oceania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Angola
Barbados
Belgium
Cyprus
Jordan
Ethiopia
Azerbaijan
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Ecuador
Bahamas
Belize
Bolivia
Italy
Algeria
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Jinxin Capital invest in?

Jinxin Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Jinxin Capital last invest?

The most recent investment recorded for Jinxin Capital closed in Aug 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Jinxin Capital Find emails